Andrieu S., Coley N., Aisen P., Carrillo M.C., DeKosky S., Durga J., Fillit H., Frisoni G.B., Froelich L., Gauthier S., Jones R., Jonsson L., Khachaturian Z., Morris J.C., Orgogozo J.M., Ousset P.J., Robert P., Salmon E., Sampaio C., Verhey F., Wilcock G., Vellas B. (2009). Methodological issues in primary prevention trials for neurodegenerative dementia, J Alzheimers Dis, 16(2), 235-270.

Ballard C.G, Gauthier S., Cummings J.L., Brodaty H., Grossberg G.T., Robert P., Lyketsos C.G. (2009). Management of agitation and aggression associated with Alzheimer disease, Nat Rev Neurol, 5(5), 245-255.

Erkinjuntti T., Gauthier S. (2009). The Concept of Vascular Cognitive Impairment, Front Neurol Neurosci , 24 , 79-85.

Ferris S., Ihl R., Robert P., Winblad B., Gatz G., Tennigkeit F., Gauthier S. (2009). Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients, Alzheimers Dement , 5 (5 ), 375-9.

Ferris S., Ihl R., Robert P., Winblad B., Gatz G., Tennigkeit F., Gauthier S. (2009). Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients, Alzheimers Dement , 5 (5 ), 369-74.

Gauthier S. (2009). Editorial: CTAD International Research Conference: Clinical Trials in Alzheimer's Disease, J Nutr Health Aging , 13 (3 ), 204.

Gauthier S. (2009). Psychopharmacology for the clinician: should we treat patients with verymild Alzheimer disease with acholinesterase inhibitor? , J Psychiatry Neurosci, 34(6), 480.

Gauthier S. (2009). Pharmacotherapy of Parkinson Disease Dementia and Lewy Body Dementia, Front Neurol Neurosci , 24 , 135-139.

Gauthier S. (2009). Dimebon improves cognitive function in people with mild to moderate Alzheimer's disease, Evid Based Ment Health , 12 (1 ), 21.

Gauthier S. (2009). Will CSF analysis become routine in people with memory complaints?, Lancet Neurol , 8 (7 ), 595-6.

Gauthier S., Aisen P. S., Ferris S. H., Saumier D., Duong A., Haine D., Garceau D., Suhy J., Oh J., Lau W., Sampalis J. (2009). Effect of Tramiprosate in Patients with Mild-to-Moderate Alzheimer's Disease: Exploratory Analyses of the MRI Sub-Group of the Alphase Study, J Nutr Health Aging , 13 (6 ), 550-7.

Gauthier S., O'Brien J. (2009). Top cited papers in international psychogeriatrics: 3. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease, Int Psychogeriatr , 21 (3 ), 454-6.

Gauthier S., Poirier J. (2009). Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?, Alzheimers Dement, 5(2), 147-8.

Gauthier S., Spiegelman D., Piton A., Lafreniere R. G., Laurent S., St-Onge J., Lapointe L., Hamdan F. F., Cossette P., Mottron L., Fombonne E., Joober R., Marineau C., Drapeau P., Rouleau G. A. (2009). Novel de novo SHANK3 mutation in autistic patients, Am J Med Genet B Neuropsychiatr Genet , 150B (3 ), 421-4.

Hamdan F. F., Gauthier S., Spiegelman D., Noreau A., Yang Y., Pellerin S., Dobrzeniecka S., Cote M., Perreault-Linck E., Carmant L., D'Anjou G., Fombonne E., Addington A. M., Rapoport J. L., Delisi L. E., Krebs M. O., Mouaffak F., Joober R., Mottron L., Drapeau P., Marineau C., Lafreniere R. G., Lacaille J. C., Rouleau G. A., Michaud J. L. (2009). Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation, N Engl J Med , 360 (6 ), 599-605.

Hudon C., Belleville S., Gauthier S. (2009). The assessment of recognition memory using the Remember/Know procedure in amnestic mild cognitive impairment and probable Alzheimer's disease, Brain Cogn , 70 (1 ), 171-9.

Khachaturian Z. S., Cami J., Andrieu S., Avila J., Boada Rovira M., Breteler M., Froelich L., Gauthier S., Gomez-Isla T., Khachaturian A. S., Kuller L. H., Larson E. B., Lopez O. L., Martinez-Lage J. M., Petersen R. C., Schellenberg G. D., Sunyer J., Vellas B., Bain L. J. (2009). Creating a transatlantic research enterprise for preventing Alzheimer's disease, Alzheimers Dement , 5 (4 ), 361-6.

Khachaturian Z. S., Snyder P. J., Doody R., Aisen P., Comer M., Dwyer J., Frank R. A., Holzapfel A., Khachaturian A. S., Korczyn A. D., Roses A., Simpkins J. W., Schneider L. S., Albert M. S., Egge R., Deves A., Ferris S., Greenberg B. D., Johnson C., Kukull W. A., Poirier J., Schenk D., Thies W., Gauthier S., Gilman S., Bernick C., Cummings J. L., Fillit H., Grundman M., Kaye J., Mucke L., Reisberg B., Sano M., Pickeral O., Petersen R. C., Mohs R. C., Carrillo M., Corey-Bloom J. P., Foster N. L., Jacobsen S., Lee V., Potter W. Z., Sabbagh M. N., Salmon D., Trojanowski J. Q., Wexler N., Bain L. J. (2009). A roadmap for the prevention of dementia II: Leon Thal Symposium 2008, Alzheimers Dement , 5 (2 ), 85-92.

Plosker G. L., Gauthier S. (2009). Cerebrolysin: a review of its use in dementia, Drugs Aging , 26 (11 ), 893-915.

Robert P., Onyike C. U., Leentjens A. F., Dujardin K., Aalten P., Starkstein S., Verhey F. R., Yessavage J., Clement J. P., Drapier D., Bayle F., Benoit M., Boyer P., Lorca P. M., Thibaut F., Gauthier S., Grossberg G., Vellas B., Byrne J. (2009). Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders, Eur Psychiatry , 24 (2 ), 98-104.